1 ng a cognitive benefit 6 mo after completing diet therapy.

2 r approximately 11 weeks (7% weight loss) of diet therapy.

3 acebo twice daily for 26 wk while continuing diet therapy.

4 ut long-term use of medical, endoscopic, and diet therapies.

5  Psyllium therapy is an effective adjunct to diet therapy and may provide an alternative to drug ther

6 t and pediatric studies of pharmacologic and diet therapies for EoE and will facilitate meaningful tr

7 to better understand and optimize the use of diet therapy for EoE.

8 us studies comparing these two approaches to diet therapy in patients with type 2 diabetes revealed t

9 ed the issue of insulin versus oral agent or diet therapy in people with recently diagnosed type II d

10 reduction and may be useful as an adjunct to diet therapy in the management of obesity.

11 d carefully evaluate the claims made for new diet therapies, supplements, or both when counseling at-

12   In summary, intermittent fasting is a safe diet therapy that can produce clinically significant wei

13 imary prevention with a statin compared with diet therapy was $54000 per QALY to $1400000 per QALY.